About

Celerion specializes in early phase drug development as a clinical research organization (CRO). The company provides a range of services to pharmaceutical and biotechnology companies, including clinical trial design, feasibility studies, project management, and regulatory affairs. Celerion uses advanced bioanalytical techniques, particularly High Resolution Mass Spectrometry (HR MS), for metabolite profiling and identification, which enhances their research capabilities. This focus on bioanalytical sciences and their extensive experience allows Celerion to assist clients in making informed decisions during the early stages of drug development. Unlike many competitors, Celerion emphasizes speed and quality in their research processes, aiming to help clients bring new treatments to market more quickly, ultimately benefiting patients around the world.

Simplify's Take

What believers are saying

• Celerion's expansion into GLP/GCP compliant molecular and cell biology testing positions it well to support the growing field of cell and gene therapies.
• The appointment of Jo Goodman as VP of Bioanalytical Services brings extensive industry experience, potentially driving innovation and enhancing service delivery.
• H.I.G. Capital's acquisition of Celerion could provide additional resources and strategic direction, fostering further growth and development.

What critics are saying

• The acquisition by H.I.G. Capital may lead to changes in company culture or strategic priorities, potentially causing uncertainty among employees.
• The competitive landscape of CROs requires Celerion to continuously innovate and maintain high standards to retain its leadership position.

What makes Celerion unique

• Celerion's expertise in early phase drug development and advanced bioanalytical sciences, particularly in metabolite profiling using HR MS, sets it apart from other CROs.
• The company's consistent recognition with CRO Leadership Awards highlights its reputation for quality, capabilities, and reliability in the industry.
• Celerion's recent CLIA certification enhances its bioanalytical laboratory capabilities, allowing it to conduct high-complexity testing and diagnostic services.

Help us improve and share your feedback! Did you find this helpful?

YesNo